Article
Plasma high density lipoproteins: Therapeutic targeting and links to atherogenic inflammation.
Atherosclerosis - 1 Sept 2018
Tall Alan R
Abstract excerpt
Plasma HDL levels have an inverse relationship to coronary artery disease (CAD) risk, which led to the idea that increasing HDL levels therapeutically would ameliorate atherosclerosis. Human genetic deficiency of CETP caused markedly elevated HDL and moderately reduced non-HDL cholesterol levels, suggesting that CETP inhibitors might produce cardiovascular benefit. The CETP inhibitor anacetrapib reproduced the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
